Search PDMR transactions

Notifier
Name of person with notification obligation
RENÉE AGUIAR LUCANDER
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
RENÉE AGUIAR LUCANDER
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Hansa Biopharma AB
Issuer´s LEI code
549300LLEO25ZJJ3NT91
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Hansa Biopharma AB SE0002148817 Acquisition 100,000 Quantity 27.00 SEK 24/07/2025 NASDAQ STOCKHOLM AB
Share Hansa Biopharma AB SE0002148817 Acquisition 50,000 Quantity 27.40 SEK 28/07/2025 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Hansa Biopharma AB SE0002148817 Acquisition 24/07/2025 NASDAQ STOCKHOLM AB 100,000 (Quantity) 27.00 SEK
Hansa Biopharma AB SE0002148817 Acquisition 28/07/2025 NASDAQ STOCKHOLM AB 50,000 (Quantity) 27.40 SEK
Total: 150,000
<< Back